Stock Price Quote

ALEMBIC LTD.

NSE : ALEMBICLTDBSE : 506235ISIN CODE : INE426A01027Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE101.470.23 (+0.23 %)
PREV CLOSE ( ) 101.24
OPEN PRICE ( ) 101.53
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 31486
TODAY'S LOW / HIGH ( )101.10 102.65
52 WK LOW / HIGH ( )66 107.5
NSE101.650.4 (+0.4 %)
PREV CLOSE( ) 101.25
OPEN PRICE ( ) 102.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 101.65 (863)
VOLUME 447374
TODAY'S LOW / HIGH( ) 100.25 102.80
52 WK LOW / HIGH ( )66.3 107.65
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 30-07 1907
Management Info
Chirayu Amin - Chairman Malika C Amin - Managing Director
Registered Office

Address Alembic Road,,,
Vadodara,
Gujarat-390003

Phone 0265-2280550 / 2280880

Email alembic.investors@alembic.co.in

Website www.alembiclimited.com

Registrars Details
Link Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, NSE, MCX

NEWS

14May Alembic reports over 4-fold jump in Q4
Alembic has reported results for fourth quarter (Q4) and year ended Marc..
14May Alembic shines on reporting over 4-fol
Alembic is currently trading at Rs. 101.41, up by 13.60 points or 15.49%..
13May Notice of Postal Ballot
Inter alia, approved:- 1. Recommended Dividend of Rs. 2.40 (120%) per..
06May Alembic informs about loss of share ce
Alembic has informed that it enclosed the intimation dated 5th May, 2024..
16Apr Alembic informs about loss of share c
Alembic has informed that it enclosed the intimation dated 15th April, 2..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit206.8928.9
Gross Profit 236.1 1027.2
Operating Profit 253.21108.7
Net Sales 475.11522.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  26643.70 (0.58%)
M.Cap ( in Cr)56616.00
Pfizer (BSE)
peergroup  4473.85 (1.59%)
M.Cap ( in Cr)20466.85
Glaxosmithkline Phar (BSE)
peergroup  2355.75 (2.80%)
M.Cap ( in Cr)39907.83
Concord Biotech (BSE)
peergroup  1494.85 (4.43%)
M.Cap ( in Cr)15638.55
Zydus Lifesciences (BSE)
peergroup  1104.45 (5.00%)
M.Cap ( in Cr)111133.51

Shareholding Pattern

PROMOTERS 70.88%
NON-INSTITUTION 28.01%
FI/BANKS/INSURANCE 0.04%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Alembic Ltd.

Alembic Ltd. was incorporated in the year 1907. Its today's share price is 101.47. Its current market capitalisation stands at Rs 2605.57 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1231.58 Cr and Total Income of Rs.1872.71 Cr. The company's management includes Keval Thakkar, Girish Hirode, Abhijit Joshi, Rati Desai, Mayank Amin, Sameer Khera, Udit Amin, Malika C Amin, Chirayu Amin.

It is listed on the BSE with a BSE Code of 506235 , NSE with an NSE Symbol of ALEMBICLTD and ISIN of INE426A01027. It's Registered office is at Alembic Road,,Vadodara-390003, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are CNK & Associates LLP, K S Aiyer & Co., KS Aiyar & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.